Journal article · 2020 · Open access
Patient familiarity with, understanding of, and preferences for clinical trial endpoints and terminology
Cancer, 126(8), 1605–1613 · Published 22 January 2020 · DOI 10.1002/cncr.32730
In brief
“Patient familiarity with, understanding of, and preferences for clinical trial endpoints and terminology” is a 2020 journal article by Mitchell S. von Itzstein and 9 co-authors, published in Cancer. OpenAlex counts 17 citations as of 22 November 2026, which puts it in the top 8% of works published in 2020 by citations. It is open access: the full text is free to read at Cancer.
- Citations
- 17
- Most cited in
- 2024 (4)
- Field-weighted impact
- 1.29
- References
- 44
- Authors
- 10
Abstract
BACKGROUND: Although there is increased attention to designing and explaining clinical trials in ways that are clinically meaningful for patients, there is limited information on patient preferences, understanding, and perceptions of this content. METHODS: Maximum difference scaling (MaxDiff) methodology was used to develop a survey for assessing patients' understanding of 19 clinical terms and perceived importance of 9 endpoint surrogate phrases used in clinical trials and consent forms. The survey was administered electronically to individuals with metastatic breast cancer affiliated with the Metastatic Breast Cancer Alliance. Analyses were performed using Bayesian P values with statistical software. RESULTS: Among 503 respondents, 77% had a college degree, 70% were diagnosed with metastatic disease ≥2 years before survey completion, and 77% had received ≥2 lines of systemic therapy. Less than 35% of respondents reported understanding "fairly well" the terms symptomatic progression, duration of disease control, time to treatment cessation, and endpoints. Income level and time since onset of metastatic disease correlated with comprehension. Patients who had received ≥6 lines of therapy perceived that time until serious side effects (P < .001) and time on therapy (P < .001) were more important compared with those who had received only 1 line of therapy. Positively phrased parameters were associated with increased perceived importance. CONCLUSIONS: Even among educated, heavily pretreated patients, many commonly used clinical research terms are poorly understood. Comprehension and the perceived importance of trial endpoints vary over the course of disease. These observations may inform the design, discussion, and reporting of clinical trials.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
von Itzstein, M. S., Railey, E., Smith, M. L., White, C. B., Sledge, G. W., Howell, J. R., Lawton, W., Marinucci, D. M., Unni, N. G., & Gerber, D. E. (2020). Patient familiarity with, understanding of, and preferences for clinical trial endpoints and terminology. Cancer, 126(8), 1605–1613. https://doi.org/10.1002/cncr.32730
MLA 9
von Itzstein, Mitchell S., et al. “Patient familiarity with, understanding of, and preferences for clinical trial endpoints and terminology.” Cancer, vol. 126, no. 8, 2020, pp. 1605–1613. https://doi.org/10.1002/cncr.32730.
Chicago
von Itzstein, Mitchell S., Elda Railey, Mary L. Smith, Carol B. White, George W. Sledge, John R. Howell, Wendy Lawton, Donna M. Marinucci, Nisha G Unni, and David E. Gerber. 2020. “Patient familiarity with, understanding of, and preferences for clinical trial endpoints and terminology.” Cancer 126 (8): 1605–1613. https://doi.org/10.1002/cncr.32730.
Harvard
von Itzstein, M. S. et al. (2020) ‘Patient familiarity with, understanding of, and preferences for clinical trial endpoints and terminology’, Cancer, 126(8), pp. 1605–1613. doi:10.1002/cncr.32730.
IEEE
M. S. von Itzstein et al., “Patient familiarity with, understanding of, and preferences for clinical trial endpoints and terminology,” Cancer, vol. 126, no. 8, pp. 1605–1613, 2020, doi: 10.1002/cncr.32730.
BibTeX
@article{vonitzstein2020patient,
title = {{Patient familiarity with, understanding of, and preferences for clinical trial endpoints and terminology}},
author = {von Itzstein, Mitchell S. and Railey, Elda and Smith, Mary L. and White, Carol B. and Sledge, George W. and Howell, John R. and Lawton, Wendy and Marinucci, Donna M. and Unni, Nisha G and Gerber, David E.},
journal = {Cancer},
year = {2020},
volume = {126},
number = {8},
pages = {1605--1613},
doi = {10.1002/cncr.32730},
url = {https://doi.org/10.1002/cncr.32730}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2021 | 2 | |
| 2022 | 3 | |
| 2023 | 2 | |
| 2024 | 4 | |
| 2025 | 3 | |
| 2026 | 3 |
Its field-weighted citation impact is 1.29: it has been cited 1.29 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Health Professions › General Health Professions › Patient-Provider Communication in Healthcare
- patient understanding
- clinical trial endpoints
- medical terminology
- patient preferences
- metastatic breast cancer
- informed consent
- surrogate endpoints
- time on therapy
Work with this paper
Most-cited papers in Health Professions
- DETERMINATION OF SERUM PROTEINS BY MEANS OF THE BIURET REACTIONAllan Godfrey Gornall, Charles J. Bardawill, Maxima M. David · Journal of Biological Chemistry · 1949 · 16,172 citations
- Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation scienceLaura J. Damschroder, David Clark Aron, Rosalind E. Keith and 3 more · Implementation Science · 2009 · 15,527 citations
- FUNCTIONAL EVALUATION: THE BARTHEL INDEX.FLORENCE I. MAHONEY, DOROTHEA W. BARTHEL · PubMed · 1965 · 15,488 citations
- The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly PersonsDiane Podsiadlo, Sandra Richardson · Journal of the American Geriatrics Society · 1991 · 15,001 citations
- National Committee for Clinical Laboratory StandardsErika Bruck · PEDIATRICS · 1980 · 14,735 citations
Questions about this paper
How do I cite this paper in APA style?
von Itzstein, M. S., Railey, E., Smith, M. L., White, C. B., Sledge, G. W., Howell, J. R., Lawton, W., Marinucci, D. M., Unni, N. G., & Gerber, D. E. (2020). Patient familiarity with, understanding of, and preferences for clinical trial endpoints and terminology. Cancer, 126(8), 1605–1613. https://doi.org/10.1002/cncr.32730
How many times has this paper been cited?
17 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Cancer: sign in and open the PDF from this page.
Who wrote this paper?
Mitchell S. von Itzstein, Elda Railey, Mary L. Smith, Carol B. White, George W. Sledge, John R. Howell, Wendy Lawton, Donna M. Marinucci, Nisha G Unni, David E. Gerber.
What is the DOI of this paper?
10.1002/cncr.32730, permanently at https://doi.org/10.1002/cncr.32730. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.